Vitamin d and Paranasal sinus hypersecretion - a phase IV clinical study of FDA data
Paranasal sinus hypersecretion is found among people who take Vitamin d, especially for people who are female, 60+ old.
The phase IV clinical study analyzes which people take Vitamin d and have Paranasal sinus hypersecretion. It is created by eHealthMe based on reports of 224,762 people who have side effects when taking Vitamin d from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
224,762 people reported to have side effects when taking Vitamin d.
Among them, 128 people (0.06%) have Paranasal sinus hypersecretion.
What is Vitamin d?
Vitamin d has active ingredients of ergocalciferol. It is often used in low vitamin d. eHealthMe is studying from 204,350 Vitamin d users for its effectiveness, alternative drugs and more.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 661 drugs and 378 conditions by eHealthMe.
Number of Vitamin d and Paranasal sinus hypersecretion reports submitted per year:
Gender of people who have Paranasal sinus hypersecretion when taking Vitamin d*:
Age of people who have Paranasal sinus hypersecretion when taking Vitamin d *:
Common drugs people take besides Vitamin d *:
Common side effects people have besides Paranasal sinus hypersecretion *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Vitamin d and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
How severe was Paranasal sinus hypersecretion and when was it recovered:
Expand to all the drugs that have ingredients of ergocalciferol:
Alternative drugs to, pros and cons of Vitamin d:
- Vitamin d (204,350 reports)
Common Vitamin d side effects:
Browse all side effects of Vitamin d:a b c d e f g h i j k l m n o p q r s t u v w x y z
Paranasal sinus hypersecretion treatments and more:
- Paranasal sinus hypersecretion (4,043 reports)
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (661 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (378 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ergocalciferol (the active ingredients of Vitamin d) and Vitamin d (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamin D and Paranasal Sinus Hypersecretion - 3 seconds ago
- Fosfomycin Tromethamine and Singulair drug interaction - 6 seconds ago
- How effective is Isradipine for High Blood Pressure? - 6 seconds ago
- Singulair and Personality Disorder - 19 seconds ago
- Sciatica and Bleeding Disorders - 19 seconds ago
- Taxol and Non-Accidental Injury - 21 seconds ago
- Erythromycin and Premature Labor - 21 seconds ago
- Artane and Abasia - 23 seconds ago
- Budesonide and Bumetanide drug interaction - 23 seconds ago
- Haloperidol and Liver Disorder - 26 seconds ago